Laboratory Corporation of... (LH)
246.34
-0.15 (-0.06%)
At close: Feb 18, 2025, 3:59 PM
246.29
-0.02%
After-hours: Feb 18, 2025, 04:11 PM EST
undefined% (undefined)
| Bid | 237.05 |
| Market Cap | 20.60B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 8.85 |
| PE Ratio (ttm) | 27.84 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 260 |
| Volume | 198,038 |
| Avg. Volume (20D) | 547,432 |
| Open | 245.23 |
| Previous Close | 246.49 |
| Day's Range | 244.22 - 247.18 |
| 52-Week Range | 191.97 - 258.59 |
| Beta | undefined |
About LH
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Mar 29, 1990
Employees 70,000
Stock Exchange NYSE
Ticker Symbol LH
Website https://www.labcorp.com
Analyst Forecast
According to 17 analyst ratings, the average rating for LH stock is "Buy." The 12-month stock price forecast is $262.5, which is an increase of 6.56% from the latest price.
Buy 70.59%
Hold 23.53%
Sell 0.00%
Next Earnings Release
Laboratory Corporation of America is scheduled to release its earnings on Apr 24, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+4.62%
Labcorp Holdings shares are trading higher after t...
Unlock content with
Pro Subscription
6 months ago
+8.33%
Labcorp shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance above estimates.
